Reference : Choice of an adjuvant for vaccination trials
Scientific journals : Article
Life sciences : Veterinary medicine & animal health
http://hdl.handle.net/2268/24997
Choice of an adjuvant for vaccination trials
French
Vermout, Sandy [> > > >]
Denis, M. [> >]
Losson, Bertrand mailto [Université de Liège - ULg > Département des maladies infectieuses et parasitaires > Parasitologie et pathologie des maladies parasitaires >]
Mignon, Bernard mailto [Université de Liège - ULg > Département des maladies infectieuses et parasitaires > Parasitologie et pathologie des maladies parasitaires >]
2003
Annales de Médecine Vétérinaire
Annales Medecine Veterinaire
147
6
393-401
Yes
International
0003-4118
Liege
Belgique
[en] The development of new vaccines, containing protective antigens that are more and more well characterized, is hindered by the lack of adjuvants able both to amplify immune response and to control it qualitatively. A number of tumors and infectious diseases could be treated with adjuvant preparations that would adequately intensify and modulate specific immune response; in particular, the possibility to specifically induce a Th1 response seems to be of paramount importance for the prevention and for the cure of these diseases. Furthermore, these adjuvants must be as safe as possible, not only for commercial applications, but also in the respect of laboratory animals' welfare. This review describes the different adjuvants presently used in vaccinology, classifying them following their chemical nature and presenting for each category the knowledge concerning their activity and toxicity.
http://hdl.handle.net/2268/24997

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
2003-Choix d'un adjuvant lors d'essais de vaccination.pdfPublisher postprint58.84 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.